Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Project DEDUCE
NCT07089901Phase 4Recruiting
- Sponsor
- Duke University
- Start
- May 2026
- Primary completion
- Mar 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nicotine patch in Tobacco Use Disorder (TUD), sponsored by Duke University. Primary endpoint: Average number of days to smoking relapse at 6.5 months. Started May 2026; status: recruiting.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT07089901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07089901.